Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

Jan 6, 2025 · A New Phase of Multiomic Analysis. Gordon Sanghera, PhD CEO Oxford Nanopore Technologies. I n 2025, population-scale genome studies will begin expanding to an entirely new phase of multiomic ...

Jan 12, 2024 · However, biotechnology remains a profitable investment in the long term. Over the past five years, the market cap for the top 25 biotechnology companies soared nearly 78% from the combined $963. ...

Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies ...

Dec 18, 2024 · The field of cell and gene therapy has seen a wave of exciting advances in the past 12 months. Following the landmark approval of the first CRISPR-based cell therapy in late 2023, investigators ...

Jan 6, 2025 · Alex Heubeck, researcher at the Allen Institute for Immunology and lead author of the study, works with blood samples in the lab. [Allen Institute] “This technique allows you to, in a way, keep ...

Sep 15, 2023 · GEN’s first-ever Top 10 A-List of contract developers and manufacturers is here. Of the top 10 companies listed, only three are headquartered in the U.S.; the rest are based in China, Germany ...

Jan 6, 2025 · The emergence of new cell-line systems for AAV manufacturing such as packaging and producer lines brings the potential for increased process robustness and cost reduction.

May 31, 2024 · But at prices exceeding $1 million, gene editing therapies have been administered to only 250 people. Institutions working to raise that number include the companies in this A-List, which ...

Aug 8, 2024 · Two months earlier, Exscientia pruned its pipeline down to four active drug candidates in therapeutic areas that include inflammatory disease, hematology, and most notably, oncology.. The value of ...